Sign In
26 Apr 2013 12:21
ο»Ώ
26Β April 2013
Β
ADVANCED ONCOTHERAPY Plc
("Advanced Oncotherapy" or "the Company")
Β
Director Dealing
Β
Advanced Oncotherapy (AIM: AVO) announces that on 25 April 2013, Tim Lebus, Non-Executive Director, purchased two tranches of ordinary shares of 1 pence each in the share capital of the Company ("Ordinary Shares"), the first tranche of 750,000 Ordinary Shares at a price of 1.56 pence per Ordinary Share. The second tranche of 213,000 Ordinary Shares was purchased at a price of 1.545 pence per Ordinary Share.
Β
Following this purchase, Tim Lebus now holds 963,000 Ordinary Shares, representing approximately 0.37 per cent. of the issued share capital of Advanced Oncotherapy.
Β
For further information, please visit www.advancedoncotherapy.comor contact:
Β
Michael Sinclair, Chief Executive | Sandy Jamieson | Jon Levinson | Simon Hudson |
Advanced Oncotherapy Plc | Libertas Capital Corporate Finance Ltd | Peterhouse Corporate Finance | Tavistock Communications |
(NOMAD & Joint Broker) | (Joint Broker) | (Financial PR & IR) | |
+44 20 3617 8739 | +44 20 7569 9650 | +44 20 7469 0930 | +44 20 7920 3150 |
Β
Β
Follow the stocks
